Oregon urged to cover new therapy type for cancer patients on Medicaid

Cancer specialists from Seattle, San Diego and Houston will be descending on Wilsonville on Thursday to implore a state committee to cover a kind of cancer therapy. The Oregon Health Evidence Review Commission, which guides the Oregon Health Authority on coverage for Medicaid patients, will take public comments on proton therapy. This therapy is sometimes given to patients instead of traditional radiation because it does less damage to surrounding tissue. It’s also more expensive, a factor that…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news

Related Links:

[Daily News] MEDICAL experts in the country have raised considerable concern over raising cases of retinoblastoma, an eye cancer that develops in early childhood.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
[Nairobi News] It was tears of joy and high-fives at Kijabe Hospital on Wednesday as a young girl excitedly marked the end of her cancer treatment by ringing a bell.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
Objective: Although the prognostic significance of systematic inflammation-based scores, such as the neutrophil-to-lymphocyte ratio (NLR), the platelet-to-lymphocyte ratio (PLR), and the prognostic nutritional index (PNI), have been explored in pancreatic cancers, few reports have investigated the lymphocyte-to-monocyte ratio (LMR). We aimed to retrospectively investigate the prognostic value of the preoperative LMR in patients with resectable pancreatic head cancer (PHC). Methods: From 2005 to 2016, 165 patients underwent pancreatoduodenectomy for PHC. All samples of peripheral blood were collected within two weeks prior ...
Source: Medical Principles and Practice - Category: Internal Medicine Source Type: research
(Wiley) Results from a study published early online in CANCER, a peer-reviewed journal of the American Cancer Society, point to the need for improved access to medical care for sexual minority cancer survivors, in particular female survivors.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
The American Society of Clinical Oncology's 20-year study looked at 49,000 women split into two groups with varying diets
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
NEW developments in the world of science and disease prevention are constantly evolving. The power, speed and accuracy of AI could be a game changer. So are we in the midst of the greatest discoveries for the medical world? New research has shown how AI has helped in the detection of lung cancer.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Source: BMJ Comments - Category: General Medicine Source Type: forums
We present a case of a 19-month infant who was taken to the Emergency Department due to fever and a gingival lesion that did not respond to antibiotic treatment. An ultrasound study was requested to assess the presence of an abscess. However, a lesion was identified and after performing a biopsy, pathologist found it was a myeloid sarcoma. The patient was diagnosed with AML and chemotherapy treatment was started. After three cycles of treatment, the patient is currently free of disease.
Source: Revista Espanola de Cirugia Oral y Maxilofacial - Category: ENT & OMF Source Type: research
We present a case of a 19-month infant who was taken to the Emergency Department due to fever and a gingival lesion that did not respond to antibiotic treatment. An ultrasound study was requested to assess the presence of an abscess. However, a lesion was identified and after performing a biopsy, pathologist found it was a myeloid sarcoma. The patient was diagnosed with AML and chemotherapy treatment was started. After three cycles of treatment, the patient is currently free of disease.
Source: Revista Espanola de Cirugia Oral y Maxilofacial - Category: ENT & OMF Source Type: research
Publication date: Available online 18 May 2019Source: Pharmacological ResearchAuthor(s): Xiangke Yin, Xianchai Lin, Xiangrong Ren, Bo Yu, Lixian Liu, Zhimin Ye, Qishan Chen, Chunsik Lee, Weisi Lu, Dechao Yu, Xuri LiAbstractNeovascular diseases, such as many cancers and ocular disorders, are life threatening and devastating. Although anti-vascular endothelial growth factor A (VEGF-A) therapy is available, many patients are not responsive and drug resistance can develop. To try to overcome these problems, combination therapy targeting VEGF-A and platelet-derived growth factor B (PDGF-B) was tested. However, one obvious drawb...
Source: Pharmacological Research - Category: Drugs & Pharmacology Source Type: research
More News: Biotechnology | Cancer | Cancer & Oncology | Cancer Therapy | Health | Health Management | Medicaid | Proton Therapy